欧洲良性前列腺增生设备市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品（电切镜、泌尿激光、射频消融设备、前列腺支架和植入物）、手术类型（经尿道微波治疗、经尿道切除术）前列腺切除术、经尿道前列腺针消融术、激光手术、Urolift 手术等）和最终用户（医院、诊所、门诊手术中心等）
No. of Pages: 159 | Report Code: BMIRE00027126 | Category: Life Sciences
No. of Pages: 159 | Report Code: BMIRE00027126 | Category: Life Sciences
良性前列腺增生器械行业的参与者专注于高额投资开发先进的外科技术作为传统技术的替代品。采用新技术的先进设备有助于立即缓解症状并降低发病率。 2022 年 1 月，EIT Health 支持的爱尔兰初创企业 ProVerum 获得了来自 Gilde Healthcare、Lightstone Ventures 和 Atlantic Bridge 的 3122 万美元 A 轮融资。 ProVerum 开发了 ProVee，这是一种针对有症状的 BPH 男性的尖端治疗解决方案，它的目标是在最近的资金帮助下在欧洲销售其创新设备。此外，2021年6月，开发微创治疗BPH或前列腺肥大引起的尿路梗阻的医疗器械公司Zenflow, Inc.宣布完成总额2400万美元的B轮融资。该投资由 Invus Opportunities 领投，Medical Technology Venture Partners、F-Prime Capital、CloudStone Capital、Astia Angels、Golden Seeds、SV Tech Ventures 等跟投。2021 年 6 月，Procept Biorobotics 筹集了 8500 万美元，用于将其商业化AquaBeam 系统作为全球 BPH 治疗方法。通过该产品，该公司打算利用其水基机器人技术在前列腺手术领域产生影响。 G 轮融资由富达管理公司领投。研究公司，并得到 T. Rowe Price Associates、CPMG、Perceptive Advisors、Viking Global Investors 和 Duquesne Family Office 的额外支持。 BPH 治疗领域的此类投资、资金和研究补助金的增加正在推动良性前列腺增生设备市场的增长。
< p>
欧洲良性前列腺增生设备市场根据产品、手术类型进行细分、最终用户和国家。根据产品，市场分为电切镜、泌尿外科激光器、射频消融设备、前列腺支架和植入物。电切镜细分市场预计将在 2022 年占据最大的市场份额。另一方面，泌尿外科激光细分市场预计在预测期内复合年增长率最高。根据手术类型，欧洲良性前列腺增生器械市场分为经尿道微波治疗、经尿道前列腺切除术、经尿道前列腺针消融术、激光手术、尿路提升手术等。经尿道前列腺切除术在 2022 年占据最大的市场份额，预计在预测期内也将实现最高的市场复合年增长率。根据最终用户，欧洲良性前列腺增生设备市场分为医院、诊所、门诊手术中心等。医院细分市场在 2022 年占据最大的市场份额，而诊所细分市场预计在预测期内复合年增长率最高。根据国家/地区，欧洲良性前列腺增生设备市场分为英国、德国、法国、意大利、西班牙和欧洲其他国家。 2022年，德国占据了更大的市场份额。另一方面，预计在预测期内复合年增长率也会更高。
KARL STORZ SE &两合公司；奥林巴斯公司；波士顿科学公司；泰利福公司；和 Richard Wolf GmbH 是欧洲良性前列腺增生设备市场的领先公司之一。
Strategic insights for Europe Benign Prostatic Hyperplasic Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 648.39 Million |
| Market Size by 2028 | US$ 994.84 Million |
| Global CAGR (2022 - 2028) | 7.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Benign Prostatic Hyperplasic Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Benign Prostatic Hyperplasic Devices Market is valued at US$ 648.39 Million in 2022, it is projected to reach US$ 994.84 Million by 2028.
As per our report Europe Benign Prostatic Hyperplasic Devices Market, the market size is valued at US$ 648.39 Million in 2022, projecting it to reach US$ 994.84 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The Europe Benign Prostatic Hyperplasic Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Benign Prostatic Hyperplasic Devices Market report:
The Europe Benign Prostatic Hyperplasic Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Benign Prostatic Hyperplasic Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Benign Prostatic Hyperplasic Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Benign Prostatic Hyperplasic Devices Market
